A randomised single-blind study to improve health-related quality of life as measured by the SF-36 vitality score by correcting anaemia of chronic kidney disease with Aranesp (darepoetin alfa) in the

  • Fraenkel, Margaret (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date21/11/06 → 29/01/08